For all our research and awards news, please visit our news page.
Monday 13 November 2017
Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support
Stephen Opat, EA Hawkes published in the Journal of Clinical Oncology.
No comments:
Post a Comment